NCT02305901View on ClinicalTrials.gov

The Effect of Multiple Doses of BI 187004 on the Single-dose Pharmacokinetics of Repaglinide and Bupropion in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Healthy
Interventions
DRUG

repaglinide

single dose on day 1 of visits 2 and 3

DRUG

BI 187004 tablet

multiple doses on days 8-13 of visit 2 and days 1-7 of visit 3

DRUG

bupropion extended release tablet

single dose on day 3 of visits 2 and 3

Trial Locations (1)

Unknown

1307.20.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02305901 - The Effect of Multiple Doses of BI 187004 on the Single-dose Pharmacokinetics of Repaglinide and Bupropion in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter